AU2001243189B2 - Pharmaceutical composition - Google Patents

Pharmaceutical composition Download PDF

Info

Publication number
AU2001243189B2
AU2001243189B2 AU2001243189A AU2001243189A AU2001243189B2 AU 2001243189 B2 AU2001243189 B2 AU 2001243189B2 AU 2001243189 A AU2001243189 A AU 2001243189A AU 2001243189 A AU2001243189 A AU 2001243189A AU 2001243189 B2 AU2001243189 B2 AU 2001243189B2
Authority
AU
Australia
Prior art keywords
membrane
nail
enhancer
agent
film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2001243189A
Other languages
English (en)
Other versions
AU2001243189A1 (en
Inventor
Robert J. Gyurik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CPEX Pharmaceuticals Inc
Original Assignee
CPEX Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CPEX Pharmaceuticals Inc filed Critical CPEX Pharmaceuticals Inc
Publication of AU2001243189A1 publication Critical patent/AU2001243189A1/en
Application granted granted Critical
Publication of AU2001243189B2 publication Critical patent/AU2001243189B2/en
Assigned to CPEX PHARMACEUTICALS, INC. reassignment CPEX PHARMACEUTICALS, INC. Request for Assignment Assignors: BENTLEY PHARMACEUTICALS, INC
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001243189A 2000-02-16 2001-02-16 Pharmaceutical composition Ceased AU2001243189B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18292400P 2000-02-16 2000-02-16
US60/182,924 2000-02-16
PCT/US2001/005302 WO2001060325A1 (en) 2000-02-16 2001-02-16 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
AU2001243189A1 AU2001243189A1 (en) 2001-11-08
AU2001243189B2 true AU2001243189B2 (en) 2005-06-09

Family

ID=22670647

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001243189A Ceased AU2001243189B2 (en) 2000-02-16 2001-02-16 Pharmaceutical composition
AU4318901A Pending AU4318901A (en) 2000-02-16 2001-02-16 Pharmaceutical composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU4318901A Pending AU4318901A (en) 2000-02-16 2001-02-16 Pharmaceutical composition

Country Status (17)

Country Link
EP (1) EP1257248B1 (enExample)
JP (1) JP2005503318A (enExample)
KR (2) KR20080049148A (enExample)
CN (1) CN1422142A (enExample)
AT (1) ATE526917T1 (enExample)
AU (2) AU2001243189B2 (enExample)
BR (1) BR0108438A (enExample)
CA (1) CA2400178A1 (enExample)
HU (1) HUP0204555A3 (enExample)
MA (1) MA26883A1 (enExample)
MX (1) MXPA02008072A (enExample)
NO (1) NO20023866L (enExample)
NZ (1) NZ520749A (enExample)
PL (1) PL357111A1 (enExample)
TW (1) TWI232756B (enExample)
WO (1) WO2001060325A1 (enExample)
ZA (1) ZA200206553B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
GB0203276D0 (en) * 2002-02-12 2002-03-27 Novartis Ag Organic compounds
JP2005538156A (ja) 2002-09-05 2005-12-15 ガルデルマ・ソシエテ・アノニム 爪塗布用溶液
EP1635770B1 (en) * 2003-03-21 2009-05-27 Nexmed Holdings, Inc. Antifungal nail coat and method of use
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
JP5010125B2 (ja) * 2005-09-02 2012-08-29 有限会社日本健康科学研究センター 水虫治療用フィルム製剤
WO2007056068A2 (en) * 2005-11-02 2007-05-18 Bentley Pharmaceuticals, Inc. Macrocyclic formulations for transmembrane drug delivery
CA2633489C (en) * 2005-12-14 2013-09-24 Zars Pharma, Inc. Compositions and methods for treating dermatological conditions
JP5290582B2 (ja) * 2005-12-28 2013-09-18 帝國製薬株式会社 爪用医薬組成物
EP2112923A1 (en) 2007-01-22 2009-11-04 Targacept Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
ES2468540T3 (es) * 2009-02-13 2014-06-16 Topica Pharmaceuticals, Inc Formulación antif�ngica
EP2408299B1 (en) * 2009-03-20 2013-10-23 Stiefel Laboratories, Inc. Fatty acid monoglyceride compositions
GB201021386D0 (en) * 2010-12-16 2011-01-26 Burke Michael H A process for the manufacture of an antifungal nail lacquer
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RS62297B1 (sr) 2011-11-23 2021-09-30 Therapeuticsmd Inc Prirodne kombinovane hormonske supstitucione formulacije i terapije
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
KR101580077B1 (ko) 2015-03-28 2015-12-24 한국콜마주식회사 시크로피록스 함유 네일락카 조성물
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5264206A (en) * 1987-06-16 1993-11-23 Hoechst Aktiengesellschaft Nail lacquer with antimycotic activity, and a process for the preparation thereof
US6224887B1 (en) * 1998-02-09 2001-05-01 Macrochem Corporation Antifungal nail lacquer and method using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
US5731303A (en) * 1985-12-04 1998-03-24 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery compositions
EP0503312B1 (fr) * 1991-03-13 1997-01-08 Firmenich Sa Procédé de préparation de la 15-pentadécanolide ou de mélanges riches en cette macrolide
WO1996012467A1 (en) * 1994-10-20 1996-05-02 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5693828A (en) * 1996-05-09 1997-12-02 International Flavors & Fragrances Inc. Process for preparing lactones and intermediates therefor
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
US6495124B1 (en) * 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5264206A (en) * 1987-06-16 1993-11-23 Hoechst Aktiengesellschaft Nail lacquer with antimycotic activity, and a process for the preparation thereof
US6224887B1 (en) * 1998-02-09 2001-05-01 Macrochem Corporation Antifungal nail lacquer and method using same

Also Published As

Publication number Publication date
AU4318901A (en) 2001-08-27
BR0108438A (pt) 2003-04-01
EP1257248A1 (en) 2002-11-20
EP1257248A4 (en) 2007-10-03
EP1257248B1 (en) 2011-10-05
CA2400178A1 (en) 2001-08-23
HUP0204555A3 (en) 2004-06-28
TWI232756B (en) 2005-05-21
JP2005503318A (ja) 2005-02-03
ZA200206553B (en) 2003-11-17
ATE526917T1 (de) 2011-10-15
NO20023866D0 (no) 2002-08-15
MXPA02008072A (es) 2004-04-05
HUP0204555A2 (en) 2003-05-28
WO2001060325A1 (en) 2001-08-23
NO20023866L (no) 2002-10-01
KR20030016227A (ko) 2003-02-26
MA26883A1 (fr) 2004-12-20
KR20080049148A (ko) 2008-06-03
PL357111A1 (en) 2004-07-12
NZ520749A (en) 2004-06-25
CN1422142A (zh) 2003-06-04

Similar Documents

Publication Publication Date Title
AU2001243189B2 (en) Pharmaceutical composition
US20030049307A1 (en) Pharmaceutical composition
AU2001243189A1 (en) Pharmaceutical composition
US5346692A (en) Nail lacquer for the treatment of onychomycosis
AU642090B2 (en) Antifungal nail varnish
JP2635104B2 (ja) 抗真菌作用のあるネイルラツカー
US6495124B1 (en) Antifungal nail lacquer and method using same
CA2402267C (en) Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails
EP1067897A1 (en) An acidified composition for topical treatment of nail and skin conditions
JPH01501143A (ja) 爪への薬物の施用のための皮膜形成性製剤用ヴェヒクル、これらのヴェヒクルを基にした薬剤組成物および同じものの使用法
JPH10152433A (ja) 被膜形成性抗真菌剤組成物
ES2295820T3 (es) Formulaciones de esmalte para las uñas eficaces antimicoticamente con 2-aminotiazoles sustituidos como sustancia activa.
US20060280703A1 (en) Antimycotic nail varnish
JP3232810B2 (ja) 被膜形成型外用剤
HK1054874A (en) Pharmaceutical composition

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: CPEX PHARMACEUTICALS, INC.

Free format text: FORMER OWNER WAS: BENTLEY PHARMACEUTICALS, INC

MK14 Patent ceased section 143(a) (annual fees not paid) or expired